GSK5784283 for nasal polyps

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Aug 2026: Trial registered, NCT07782970
  2. 28 Sep 2026: Trial started, NCT07782970

The trials

NCT07782970: A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

State
Under way
Phase
Phase 3
People
218 planned
Started
28 Sep 2026
Primary completion
6 Mar 2029
Arms
Participants receiving GSK5784283 + standard of care (SoC)
Results
None posted
  1. 24 Aug 2026: Trial registered
  2. 28 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.